id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-281391-0qkku2jd	Miller-Handley, Hilary	Treatment Options for COVID-19 in Patients with Reduced or Absent Kidney Function	2020-09-17		.txt	text/plain	4720	276	47	COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, was first identified in the Hubei Province of China in late 2019. Because of these findings, chloroquine and hydroxychloroquine were used as early therapies in the treatment of COVID-19, and its use was further propagated by a small, retrospective, biased study from France with 36 patients which showed decrease in viral burden, and improved outcomes in patients treated with hydroxychloroquine [17] . A retrospective study from the Veterans Affairs, looked at hospitalized patients who received hydroxychloroquine and showed no evidence that use of hydroxychloroquine reduced the risk of progression of disease including mechanical ventilation and death [20] . Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial	./cache/cord-281391-0qkku2jd.txt	./txt/cord-281391-0qkku2jd.txt